Table 1: Demographic and Clinical Characteristics - Obj_2_AF for onscoviddeath
	Total	DOAC use	warfarin use

1	  372,746 (100.0)	  280,407 (100.0)	   92,339 (100.0)

Grouped age
1	      622 (0.2)	      510 (0.2)	      112 (0.1)
2	    2,681 (0.7)	    2,320 (0.8)	      361 (0.4)
3	   15,033 (4.0)	   12,788 (4.6)	    2,245 (2.4)
4	   52,231 (14.0)	   42,407 (15.1)	    9,824 (10.6)
5	  132,899 (35.7)	   98,848 (35.3)	   34,051 (36.9)
6	  169,280 (45.4)	  123,534 (44.1)	   45,746 (49.5)

Male
0	  159,192 (42.7)	  122,778 (43.8)	   36,414 (39.4)
1	  213,554 (57.3)	  157,629 (56.2)	   55,925 (60.6)

Grouped BMI
1	    6,636 (1.8)	    5,437 (1.9)	    1,199 (1.3)
2	   94,656 (25.4)	   72,658 (25.9)	   21,998 (23.8)
3	  126,602 (34.0)	   94,621 (33.7)	   31,981 (34.6)
4	   77,182 (20.7)	   57,590 (20.5)	   19,592 (21.2)
5	   32,146 (8.6)	   24,032 (8.6)	    8,114 (8.8)
6	   17,125 (4.6)	   12,586 (4.5)	    4,539 (4.9)
.	   18,399 (4.9)	   13,483 (4.8)	    4,916 (5.3)

Smoking status
1	  134,497 (36.1)	  101,492 (36.2)	   33,005 (35.7)
2	  216,215 (58.0)	  161,752 (57.7)	   54,463 (59.0)
3	   21,662 (5.8)	   16,828 (6.0)	    4,834 (5.2)
.	      372 (0.1)	      335 (0.1)	       37 (0.0)

Ethnicity
1	  267,846 (71.9)	  201,046 (71.7)	   66,800 (72.3)
2	      663 (0.2)	      548 (0.2)	      115 (0.1)
3	    4,677 (1.3)	    3,911 (1.4)	      766 (0.8)
4	    1,547 (0.4)	    1,289 (0.5)	      258 (0.3)
5	    1,381 (0.4)	    1,100 (0.4)	      281 (0.3)
.	   96,632 (25.9)	   72,513 (25.9)	   24,119 (26.1)

Index of Multiple Deprivation (IMD)
1	   75,273 (20.2)	   57,570 (20.5)	   17,703 (19.2)
2	   75,281 (20.2)	   56,881 (20.3)	   18,400 (19.9)
3	   74,710 (20.0)	   55,654 (19.8)	   19,056 (20.6)
4	   73,373 (19.7)	   54,758 (19.5)	   18,615 (20.2)
5	   74,109 (19.9)	   55,544 (19.8)	   18,565 (20.1)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	  256,171 (68.7)	  195,719 (69.8)	   60,452 (65.5)
2	   85,071 (22.8)	   61,178 (21.8)	   23,893 (25.9)
3	   30,368 (8.1)	   22,672 (8.1)	    7,696 (8.3)
4	    1,136 (0.3)	      838 (0.3)	      298 (0.3)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diagnosed hypertension
1	  261,966 (70.3)	  195,078 (69.6)	   66,888 (72.4)
Heart Failure
1	   98,353 (26.4)	   71,427 (25.5)	   26,926 (29.2)
Diabetes
1	  116,575 (31.3)	   84,688 (30.2)	   31,887 (34.5)
COPD
1	   47,461 (12.7)	   36,189 (12.9)	   11,272 (12.2)
Other Respiratory Diseases
1	   21,175 (5.7)	   16,444 (5.9)	    4,731 (5.1)
Cancer
1	   65,728 (17.6)	   49,488 (17.6)	   16,240 (17.6)
Immunosuppressed (combination algorithm)
1	    2,216 (0.6)	    1,688 (0.6)	      528 (0.6)
Chronic kidney disease
1	  130,348 (35.0)	   95,715 (34.1)	   34,633 (37.5)
Flu vaccine
1	  298,711 (80.1)	  220,153 (78.5)	   78,558 (85.1)
Recent Oestrogen
1	    2,013 (0.5)	    1,652 (0.6)	      361 (0.4)
Recent antiplatelet
1	   23,138 (6.2)	   19,030 (6.8)	    4,108 (4.4)
Myocardial infarction
1	   42,325 (11.4)	   31,911 (11.4)	   10,414 (11.3)
Peripheral arterial disease
1	   19,364 (5.2)	   14,273 (5.1)	    5,091 (5.5)
Stroke/Transient ischaemic attack
1	   78,741 (21.1)	   60,271 (21.5)	   18,470 (20.0)
Venous thromboembolism
1	   28,129 (7.5)	   19,927 (7.1)	    8,202 (8.9)
Stroke
1	   59,397 (15.9)	   45,419 (16.2)	   13,978 (15.1)
Transient ischaemic attack
1	   43,215 (11.6)	   32,380 (11.5)	   10,835 (11.7)
Recent NSAID
1	    4,519 (1.2)	    4,059 (1.4)	      460 (0.5)
Recent aspirin
1	   14,178 (3.8)	   11,540 (4.1)	    2,638 (2.9)
Hazardous alcohol use
1	   36,194 (9.7)	   28,375 (10.1)	    7,819 (8.5)


GP consultation count
Median (IQR)	11 (6-20)	10 (6-17)	16 (9-27)
Min, Max	0, 432	0, 432	0, 307
Age (years)
Median (IQR)	78 (72-85)	78 (71-84)	79 (73-85)
Min, Max	18, 107	18, 107	24, 105
A&E attendance count
Median (IQR)	0 (0-1)	0 (0-1)	0 (0-1)
Min, Max	0, 69	0, 69	0, 45
Recent record of HAS-BLED score
Median (IQR)	1 (1-2)	1 (1-2)	1 (1-2)
Min, Max	0, 9	0, 9	0, 7
Ever record of HAS-BLED score in 10 years
Median (IQR)	1 (1-2)	1 (1-2)	1 (1-2)
Min, Max	0, 9	0, 9	0, 9
